ADMA Biologics Inc — Quarterly Financial Statistics (NASDAQ:ADMA) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities 25.03 M50.22 M19.68 M-18.21 M13.29 M35.64 M 50.4 M Cash from investing activities 1.1 M2.75 M4.72 M2.53 M14.37 M276 K 21.89 M Cash from financing activities 25.47 M31.03 M7.13 M-48 K27.82 M9.12 M 44.02 M Free cash flow 23.93 M47.47 M14.96 M-20.74 M-1.07 M34.36 M 27.5 M

Haberler

Alkermes Down Despite Q4 Earnings Beat, Announces Leadership Change

ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance

Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues

ADMA Biologics Inc kazancı $0,03 ile beklentilere göre daha iyi, kâr ise beklentilere göre düşük

ADMA Biologics Inc earnings beat by $0.03, revenue fell short of estimates

ADMA Biologics kazanç açıklaması yaklaşıyor: Hedeflere ulaşabilecek mi?

Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?

Adma Biologics Başkanı Adam Grossman, 337.679 dolar değerinde hisse satışı gerçekleştirdi

Adam Grossman, president of Adma Biologics, sells $337,679 in shares

Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer

NeoGenomics Announces Launch of New Cancer Assay PanTracer Pro

Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note